Vaccitech Plc
Vaccitech Plc:
Proprietary ChAdOx (prime) and MVA (boost) technology platform induces CD8+ T cell and antibody immune responses to treat and prevent infectious diseases and cancer. Broad therapeutic pipeline. Ph1/2a full efficacy for VTP-300 (HBV functional cure) expected H22022 and VTP-200 (high-risk HPV therapeutic) Ph1/2a interim efficacy data expected 4Q2022. Encouraging prostate cancer, 5T4 immunotherapeutic data. Ph1/2a NSCLC MAGE-NYESO immunotherapeutic interim data expected Q42023m first patient dosed Q12022. $15M royalty revenue during Q42021 from AstraZeneca's commercial sales of Vaxzevria® (out-licensed ChAdOx COVID-19 vaccine). Avidea Technologies (private) acquisition expands product pipeline with complementary SNAPvax platform
Sector/Industry:
Healthcare/Biotechnology
Characteristics:
Based in...
Europe
Clinical Stage
Phase l or ll
Disease Space
COVID-19, Immunotherapy, Infectious Disease, Oncology
Finance
Revenues
Industry
Biotechnology
Investment Strategy
Under the Radar
Listing
Public, USA
Market Cap
<100MM
Therapeutic Modalities
Vaccine
Website:
Profiles:
Address:
The Schrodinger Building, Heatley Road
The Oxford Science Park
Oxford, OX4 4GE
United Kingdom
The Oxford Science Park
Oxford, OX4 4GE
United Kingdom
More info:
My account:
Top 10 Holders of Vaccitech Plc Sponsored ADR
| Institution | OS (%) | Position | Mkt Val ($MM) | Source | Filing Date |
|---|---|---|---|---|---|
| M&G Investment Management Ltd. | 13.56 | 5,197,349 | 12.53 | 13F | 3/31/23 |
| Alphabet, Inc. | 3.95 | 1,513,644 | 3.65 | 13F | 3/31/23 |
| SC China Holdings Ltd. | 3.71 | 1,420,473 | 3.42 | 13F | 3/31/23 |
| DC Funds LP | 1.68 | 642,204 | 1.55 | 13F | 3/31/23 |
| BlueCrest Capital Management (UK) LLP | 1.42 | 542,673 | 1.31 | 13F | 3/31/23 |
| Liontrust Investment Partners LLP | 1.19 | 455,848 | 1.10 | 13F | 3/31/23 |
| Liontrust Investment Management Ltd. | 0.99 | 379,416 | 0.91 | Funds | 4/28/23 |
| Robert W. Baird & Co., Inc. (Equity) | 0.47 | 179,296 | 0.43 | 13F | 3/31/23 |
| The Johns Hopkins University | 0.28 | 107,968 | 0.26 | 13F | 3/31/23 |
| Morgan Stanley & Co. LLC | 0.18 | 67,099 | 0.16 | 13F | 3/31/23 |
Ownership data is sourced through FactSet.
Stock Market Data
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2023 QuoteMedia.
Data delayed 15 minutes unless otherwise indicated (view
delay times for all
exchanges). RT=Real-Time, RTB=Real-Time
BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time
NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of
Day, PD=Previous Day. Market Data powered by
QuoteMedia.
Terms of Use.